Multi-scale Modeling of Influenza Vaccination for Optimal T-cell Immunity

Investigators
Veronika Zarnitsyna, Jacob Kohlmeier
Contact info (email)
vizarni@emory.edu
1. Define context(s)
reveal new biological insights
other
Current Conformance Level / Target Conformance Level
Extensive
Primary goal of the model/tool/database

The primary goal is to model how prior T-cell immunity (from infections and vaccinations) affects the dynamics of infection and transmission following exposure to drifted and shifted influenza strains using a multi-scale modeling approach. Animal and human studies showed that T cells can provide strain-transcending protection, resulting in more rapid viral clearance, decreased immunopathology, and improved clinical outcomes, and thus the improvement of strategies to induce protective levels of influenza-specific T cells are of critical importance. We estimate waning of T cell immunity in a mouse model, and how it affects the protection to new strains of influenza. We also explore how the antigenic distance from prior immunity for the live-attenuated influenza vaccine affects generation of optimal protective immunity. Mice studies will inform how to better interpret the limited information about immunity waning available in human studies. Using multi-scale modeling approach we explore how waning of immunity affects the influenza epidemic size and severity. The knowledge gained form this study will help guide future vaccination efforts against influenza viruses to better generate broadly protective T cell immunity within individuals and across the population.

Biological domain of the model
Immunology and epidemiology
Structure(s) of interest in the model
Respiratory system (lungs) and immune system (lymph nodes)
Spatial scales included in the model
Cell level to population level
Time scales included in the model
Hours, months
Other uses for the model (optional)

This model can be generalized to other diseases and/or locations in the body with simple parameter changes. 

2. Data for building and validating the model
Data for building the model Published? Private? How is credibility checked? Current Conformance Level / Target Conformance Level
in vitro (primary cells cell, lines, etc.) On BioRxiv In progress peer review Extensive
ex vivo (excised tissues)
in vivo pre-clinical (lower-level organism or small animal) On BioRxiv In progress peer review Extensive
in vivo pre-clinical (large animal)
Human subjects/clinical
Other: ________________________ IEDB, NMDP (published online databases) replicated experiments Extensive
Data for validating the model Published? Private? How is credibility checked? Current Conformance Level / Target Conformance Level
in vitro (primary cells cell, lines, etc.)
ex vivo (excised tissues)
in vivo pre-clinical (lower-level organism or small animal) In progress Partial
in vivo pre-clinical (large animal)
Human subjects/clinical
Other: ________________________ Simulated data Partial
3. Validate within context(s)
Who does it? When does it happen? How is it done? Current Conformance Level / Target Conformance Level
Verification Ph.D. student, postdoc, PI Throughout Testing of controlled cases with known outcomes Adequate
Validation Ph.D student, postdoc As data becomes available Model comparison to data Adequate
Uncertainty quantification
Sensitivity analysis Ph.D, postdoc Throughout Parameter variation comparisons Adequate
Other:__________
Additional Comments
4. Limitations
Disclaimer statement (explain key limitations) Who needs to know about this disclaimer? How is this disclaimer shared with that audience? Current Conformance Level / Target Conformance Level
No current age specific differences Scientific community Explicit statement in both code and work Adequate
Assumed homogeneity in individual parameters Scientific community Explicit statement in both code and work Adequate
5. Version control
Current Conformance Level / Target Conformance Level
Extensive
Naming Conventions? Repository? Code Review?
individual modeler Yes Yes Yes
within the lab Yes Yes Yes
collaborators Yes
6. Documentation
Current Conformance Level / Target Conformance Level
Code commented? Extensive
Scope and intended use described? Adequate
User’s guide? Adequate
Developer’s guide? Partial
7. Dissemination
Current Conformance Level / Target Conformance Level
Adequate
Target Audience(s): “Inner circle” Scientific community Public
Simulations Dropbox In progress, currently under development
Models Dropbox, Github In progress, currently under development Public Github as available
Software Dropbox, Github In progress, currently under development Public Github as available
Results Dropbox, Github, lab meetings Publications, conferences Public Github as available
Implications of results Dropbox, Github, lab meetings Publications, conferences
8. Independent reviews
Current Conformance Level / Target Conformance Level
Adequate
Reviewer(s) name & affiliation: Unknown, blind peer review
When was review performed? 2019, another additional planned review for year 3
How was review performed and outcomes of the review? Peer reviewed publication, accepted
9. Test competing implementations
Current Conformance Level / Target Conformance Level
Adequate
Yes or No (briefly summarize)
Were competing implementations tested? Yes
Did this lead to model refinement or improvement? Yes
10. Conform to standards
Current Conformance Level / Target Conformance Level
Adequate
Yes or No (briefly summarize)
Are there operating procedures, guidelines, or standards for this type of multiscale modeling? Yes
How do your modeling efforts conform? Well
11. (optional) Additional information to support items 1-10

Our computational model is still in year two early stage development.